Upcoming Allied Market Research
Cancer Cachexia Market

Cancer Cachexia Market

Global Opportunity Analysis and Industry Forecast, 2021-2031

Report Code: A08106
Pages: NA
Mar 2023 | 1412 Views
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.



Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Cancer Cachexia Market

Request Now !

Cancer cachexia is a wasting syndrome characterized by weight loss, anorexia, asthenia and anemia. The pathogenicity of this syndrome is a result multiple factors, due to a complex interaction of tumor and host factors.  It is generally related with chronic inflammatory conditions and cancer. Cachexia is a serious condition as it consumes other sources of energy, like skeletal muscle and adipose tissue when the body senses a lack of nutrition. It adversely affects the patients’ ability to fight against infection and withstand ongoing treatments such as chemotherapy and radiotherapy. As a result of these negative effects, the body begins to waste away leading to death. Clinical trials in progress in oncology field have highlighted the multifactorial pathogenicity of cachexia. Understanding the mechanism of cancer cachexia has become crucial for the understanding of prognostic factors for cancer. Cachexia is often a permanent side effect of diseases like HIV and Cancer. Biologics and pharmaceutical organizations are adopting practices that ensure the availability of the product in the market at a rapid pace. This strategic approach is helping them bolster their position in the global cancer cachexia market. 

COVID – 19 scenario analysis:

  • Due to the COVID – 19  outbreak, majority of healthcare, pharmaceutical and biotechnology organizations have concentrated on diagnostics kits, safety wearables (PPE kits, face shields, masks) and treatment therapies and medication against Novel coronavirus
  • R&D labs are also focusing on finding a breakthrough vaccine against novel coronavirus
  • In addition, the medical professionals are engaged in providing COVID-19 related services, as a result, other healthcare segments  have to face negligence
  • As there is strain on healthcare providers and the hospitals are flooding with patients suffering with novel coronavirus and the intake capacity of hospitals already at its peak, the cancer cachexia patients and their treatments have been either postponed or put on hold as the health professionals are summoned to fight COVID-19
  • Some research from China, has also stated that cancer patients are at higher risk as they’re vulnerable against  novel coronavirus and have higher chances of getting infected with the virus

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

Factors like increasing prevalence of cancer and cancer cachexia in patients, the demand for therapeutic treatment and drugs have increased all over. This rising demand for therapeutics in the market has accelerated the R&D activities in order to develop novel therapeutic drugs. This has led to creation of a strong product pipeline consisting various therapy products. These factors have been major reason for the growth of the market. In addition, increased awareness has regarding this syndrome and advancements related to treatment of cancer cachexia has also helped the market growth. Randomized trials have highlighted the growing potential of new chemotherapy agents. The use of combination chemotherapy in the adjuvant setting to improve survival rates has been positive. The cancer cachexia market will gather significant pace due to growing awareness about improving the quality of life for cancer patients. Researchers are experimenting in the search of specific drugs to cure this syndrome using pharmacological treatments with diverse chemical compounds. The non-steroidal anti-inflammatory drugs (NSAIDs) have shown promising results in this scenario.

On the contrary, lack of studies and research that could explain high efficacy of a specific treatment, making the progress in the cancer cachexia market has been considerably at slower pace. The manufacturers of cancer cachexia drugs are hesitant while investing in the market because of the stringent regulatory guideline which may restrict the long-term growth of this market.

Use of multidisciplinary approach and development of combined therapies to surge the market growth

According to National Center for Biotechnology Information (NCBI), it is estimated that half of all patients suffering with cancer will develop cancer cachexia, leading to progressive loss of adipose tissue and skeletal muscle mass. Cachexia syndrome has dramatic impacts on patient quality of life along with poor responses to treatments like chemotherapy and decreased survival chances. But still, cachexia is underestimated and untreated condition, despite numerous mechanisms reported to be engaged in its development. Therapies for treatment of cachexia include or exigenic appetite stimulants, focus on palliation of symptoms and reduction of the distress of patients. The past therapies haven’t been much effective as they were targeting a single aspect of this syndrome while multi-faceted approach was needed. Recent developments in therapies for cancer cachexia feature multiple integrated approaches. For instance, combination therapy supplemented with diet modification and exercise routine has been an addition conventional to novel pharmaceutical agents, such as Megestrol, medroxyprogesterone, ghrelin, omega-3-fatty acid among others. The use of these agents along with diet and exercise regime reported to have improved survival rates as well as quality of life for the patient. These advancements would prove to be a boon for patients struggling with cancer cachexia syndrome and boost the growth of the cancer cachexia market in the years to come.

North American region expected to dominate the Cancer Cachexia Market

The U.S. alone accounted for an estimated 1.8 million cancer patients and over 606,000 deaths in 2019 and this number is expected to grow with time.  American region is expected to grow due to factors like rising incidence of cancer patients and hence cancer cachexia as well with the presence of large number of drug manufacturers and key players in the market along with advancing paradigm of care for cancer patients that is supporting the growth in this region. As a result, this segment holds the largest market share. Furthermore, factors such as a rising number of geriatric population along with an increasing healthcare spending in the region and the availability of advanced healthcare infrastructure would to stimulate the market growth in this region. 

Key benefits of the report:

  • This study presents the analytical depiction of the global cancer cachexia industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global market share.
  • The current market is quantitatively analysed from 2020 to 2027 to highlight the global cancer cachexia market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Cancer Cachexia Market research report:

  • Who are the leading market players active in the cancer cachexia market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that will help in taking further strategic steps?

Cancer Cachexia Market Report Highlights

Aspects Details
By Drugs
  • Progestogens
  • Corticosteroids
  • Combination Therapies
  • Others
By Mode of action
  • Appetite Stimulators
  • Weight Loss Stabilizers
  • Others
By Distribution channels
  • Hospital Stores
  • Retail Pharmacy
  • Online Pharmacy
By Region
  • North America  (US, Canada, Mexico)
  • Europe  (France, Germany, UK, Italy, Spain, rest of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, rest of Asia-Pacific)
  • LAMEA  (Brazil, South Arabia, South Africa, rest of LAMEA)
Key Market Players Eterna Zentaris, Alder BioPharmaceuticals Inc., Eli Lilly and Company, GTx Inc., Merck & Co. Inc., Novartis AG, Bristol-Myers Squibb Company, XBiotech, Inc., Pernix Therapeutics, Pfizer Inc, Purdue Pharma L.P., Sanofi, SkyePharma, Takeda Pharmaceutical Company.

Loading Table Of Content...

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Cancer Cachexia Market

Start reading.
This Report and over 19,665+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise

  • $9,870
  • Unlimited
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library

  • $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
  • Company Profiles
  • Newly Added Content Access
  • 10 PDF
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD


Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs


Targeted market view to provide pertinent information and save time of readers